chr6-31864874-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025257.3(SLC44A4):c.1868C>T(p.Pro623Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_025257.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC44A4 | NM_025257.3 | c.1868C>T | p.Pro623Leu | missense_variant | 19/21 | ENST00000229729.11 | NP_079533.2 | |
SLC44A4 | NM_001178044.2 | c.1742C>T | p.Pro581Leu | missense_variant | 18/20 | NP_001171515.1 | ||
SLC44A4 | NM_001178045.2 | c.1640C>T | p.Pro547Leu | missense_variant | 19/21 | NP_001171516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC44A4 | ENST00000229729.11 | c.1868C>T | p.Pro623Leu | missense_variant | 19/21 | 1 | NM_025257.3 | ENSP00000229729 | P1 | |
SLC44A4 | ENST00000375562.8 | c.1742C>T | p.Pro581Leu | missense_variant | 18/20 | 2 | ENSP00000364712 | |||
SLC44A4 | ENST00000544672.5 | c.1640C>T | p.Pro547Leu | missense_variant | 19/21 | 2 | ENSP00000444109 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152024Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251054Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135764
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461846Hom.: 0 Cov.: 34 AF XY: 0.0000206 AC XY: 15AN XY: 727220
GnomAD4 genome AF: 0.000138 AC: 21AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.1868C>T (p.P623L) alteration is located in exon 19 (coding exon 19) of the SLC44A4 gene. This alteration results from a C to T substitution at nucleotide position 1868, causing the proline (P) at amino acid position 623 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. This variant has not been reported in the literature in individuals affected with SLC44A4-related conditions. This variant is present in population databases (rs114240969, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 623 of the SLC44A4 protein (p.Pro623Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at